WallStSmart
MOLN

Molecular Partners AG ADR

NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY

$4.23
-4.94% today

Updated 2026-04-30

Market cap
$162.74M
P/E ratio
P/S ratio
158.42x
EPS (TTM)
$-2.10
Dividend yield
52W range
$3 – $5
Volume
0.0M

Molecular Partners AG ADR (MOLN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-8.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-20.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-8.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-13.1%
2026-03-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-12$-0.36+7.2%$4.86$4.22-13.1%
2025-10-30$-0.40+16.1%$3.75$3.63-3.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.39$-0.36+7.2%
2025-09-30$-0.48$-0.40+16.1%
2025-06-30$-0.50$-0.69-37.5%
2025-03-31$-0.37$-0.45-21.6%
2024-12-31$-0.39$-0.30+23.1%
2024-09-30$-0.63$-0.56+10.5%$681000.00-73.2%
2024-06-30$-1.26$-0.46+63.5%$1.55M+273.7%
2024-03-31$-1.00$-0.60+40.0%$2.74M-10.2%
2023-12-31$-0.97$-0.60+38.1%$1.03M
2023-09-30$0.00$-0.39$2.54M
2023-06-30$-0.87$-0.54+37.7%$415000.00
2023-03-31$0.00$-0.49$3.05M

Frequently asked questions

Has Molecular Partners AG ADR beaten earnings estimates?
Molecular Partners AG ADR has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -8.9% over the last 4 quarters.
How does MOLN stock react to earnings?
MOLN stock has moved an average of -8.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.